(MENAFN) The Ministry of Health and Prevention (MOHAP) and GlaxoSmithKline Export Limited (GSK) were confirmed to have signed a strategic deal for the provision and supply of medical and pharmaceutical stocks in emergency situations.
The deal is considered to be in line with efforts to reinforce medical health security of the UAE.
The agreement provides a list of medicines which include a number of products for o respiratory diseases, nervous system diseases, infections, urology diseases, genecology and obstetrics, immune system disorders, and other chronic diseases.
Undersecretary of the Ministry Dr. Mohammed Salim Al Olama has appeared at the signing ceremony, along with Dr. Abdul Karim Abdullah Al Zarouni, Director of Emergency, Crisis and Disaster Operations Center at the Ministry.
MENAFN2207201800450000ID1097183482
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.